LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2)
- PMID: 15919106
- DOI: 10.1016/j.ygyno.2005.03.004
LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2)
Abstract
Objective: Lysophosphatidic acid (LPA) stimulates ovarian tumor growth partially via induction of VEGF expression through transcriptional activation. Previous studies have shown that LPA induces epithelial ovarian cancer (EOC) in vitro metastasis. In this study, we examined the role of VEGF in LPA-induced EOC invasion and migration and underlying mechanisms.
Methods: The invasiveness of DOV13 cells was determined by in vitro basement membrane Matrigel invasion assay. Ovarian carcinoma cellular migration was quantified by the colloidal gold migration assay. Matrix metalloproteinase (MMP)-2 secretion and activation were detected by gelatin zymography. Urokinase type plasminogen activator (uPA) activity was determined by a coupled colorimetric assay measuring the activity of generated plasmin. Student's t test and one-way ANOVA were used for statistical analysis.
Results: Using a VEGF neutralizing monoclonal antibody (mAb), we show that LPA-induced EOC invasion is dependent upon VEGF. Using the selective VEGF receptor (VEGFR)-2 inhibitor, SU1498, LPA-induced EOC invasion and migration were significantly inhibited in a concentration-dependent manner. In addition, SU1498 inhibits MMP-2 secretion and uPA activity in ovarian cancer DOV13 cells. At 5 and 20 microM, SU1498 almost completely inhibited the activity of MMP-2 and uPA. SU1498 also decreases the LPA-induced increase of uPA activity in DOV13 cells.
Conclusions: Our results show that LPA-induced EOC invasion is at least partially mediated by VEGF. Further, the VEGFR-2-mediated signaling transduction pathway may be involved in LPA-induced EOC invasion and migration by regulating the secretion and activation of MMP-2 and uPA.
Similar articles
-
The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).Gynecol Oncol. 2011 Oct;123(1):129-37. doi: 10.1016/j.ygyno.2011.06.006. Epub 2011 Jul 22. Gynecol Oncol. 2011. PMID: 21782227
-
Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases.Int J Cancer. 2006 Feb 15;118(4):879-88. doi: 10.1002/ijc.21421. Int J Cancer. 2006. PMID: 16152587
-
VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.Gynecol Oncol. 2009 Dec;115(3):414-23. doi: 10.1016/j.ygyno.2009.08.019. Epub 2009 Sep 18. Gynecol Oncol. 2009. PMID: 19765808
-
Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.IUBMB Life. 2005 Jun;57(6):441-7. doi: 10.1080/15216540500159424. IUBMB Life. 2005. PMID: 16012053 Review.
-
[Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].Nihon Sanka Fujinka Gakkai Zasshi. 1996 Aug;48(8):623-32. Nihon Sanka Fujinka Gakkai Zasshi. 1996. PMID: 8808830 Review. Japanese.
Cited by
-
Aiming drug discovery at lysophosphatidic acid targets.Br J Pharmacol. 2010 Sep;161(2):241-70. doi: 10.1111/j.1476-5381.2010.00815.x. Br J Pharmacol. 2010. PMID: 20735414 Free PMC article. Review.
-
Autotaxin production in the human breast cancer tumor microenvironment mitigates tumor progression in early breast cancers.Am J Cancer Res. 2023 Jul 15;13(7):2790-2813. eCollection 2023. Am J Cancer Res. 2023. PMID: 37559999 Free PMC article.
-
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Cancer Metastasis Rev. 2012 Jun;31(1-2):143-62. doi: 10.1007/s10555-011-9337-5. Cancer Metastasis Rev. 2012. PMID: 22101807 Free PMC article. Review.
-
Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae.Cancers (Basel). 2020 Feb 6;12(2):374. doi: 10.3390/cancers12020374. Cancers (Basel). 2020. PMID: 32041123 Free PMC article. Review.
-
Fe-MIL-101 exhibits selective cytotoxicity and inhibition of angiogenesis in ovarian cancer cells via downregulation of MMP.Sci Rep. 2016 May 18;6:26126. doi: 10.1038/srep26126. Sci Rep. 2016. PMID: 27188337 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous